Vimarsana
Biggest News Aggregation in the World

Page 18 - Cell Proliferation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Proliferation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Proliferation Today - Breaking & Trending Today

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gen - Vimarsana News

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gen

LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...

Echinacoside against Endometrial Cancer - Vimarsana News

Echinacoside against Endometrial Cancer

A compound - target - disease network was constructed to explore the potential targets and mechanism of Echinacoside against endometrial Cancer.

ValenzaBio Engages ProBioGen For a Second Service Project - Vimarsana News

ValenzaBio Engages ProBioGen For a Second Service Project

  BERLIN, Germany and BETHESDA, MD, USA, June 14, 2022 / B3C newswire / -- ProBioGen and ValenzaBio jointly announce today that they have entered into a second service agreement.The new project is a continuation of successfully completed cell line development work that utilized ProBioGen's proprietary tech...

Discovery explains why patients with severe asthma are unresponsive to treatment - Vimarsana News

Discovery explains why patients with severe asthma are unresponsive to treatment

Patients with the most severe form of asthma produce special substances in their airways when taking medicine during an asthma attack that block the treatment from working, according to a study where Rutgers scientists collaborated with researchers at Genentech, a member of the Roche Group.

Spotlight on Lucas Sullivan - Vimarsana News

Spotlight on Lucas Sullivan

Spotlight on Dr. Lucas Sullivan. Dr. Sullivan studies cell metabolism under normal and cancerous conditions.